SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
沐小羚
Lv2
170 积分
2024-09-16 加入
最近求助
最近应助
互助留言
Identification of Hub Biomarkers and Immune Cell Infiltration Characteristics in Ulcerative Colitis by Bioinformatics Analysis and Machine Learning
3天前
已完结
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium
3个月前
已完结
Proactive Therapeutic Drug Monitoring of Ustekinumab Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease
3个月前
已完结
Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series
3个月前
已完结
Incidence and Risk Factors for Development of Acne (JAKne) in Patients with Inflammatory Bowel Disease Treated With Upadacitinib
3个月前
已关闭
Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial
4个月前
已完结
Systematic review with meta‐analysis: loss of response and requirement of ustekinumab dose escalation in inflammatory bowel diseases
1年前
已完结
Pharmacogenomics and the Resulting Impact on Psoriasis Therapies
1年前
已完结
A polymorphism in the gene encoding the Fc IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis
1年前
已完结
A novel PCR-based method for direct Fcγ receptor IIIa (CD16) allotyping
1年前
已完结
没有进行任何应助
不需要了【积分已退回】
3个月前
帮大忙了
1年前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论